External Ventricular Drain Market Report
First published: 11 October 2024 | Last updated: 25 May 2026 | Report Code: external-ventricular-drain
External Ventricular Drain Market — USD $1.5 Billion in 2023, Growing to USD 2.95null by 2033 at 6.8% CAGR
This report provides a comprehensive analysis of the External Ventricular Drain market for the forecast period from 2023 to 2033. It encompasses market size, growth trends, segmentation, regional insights, and leading players, offering valuable data for stakeholders and decision-makers.
Key Takeaways
- Global market expands from $1.50 Billion in 2023 to $2.95 Billion in 2033 with a 6.8% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe grows from $0.39 Billion to $0.77 Billion between 2023 and 2033, reflecting sustained clinical adoption.
- Top companies include B. Braun Melsungen AG, Medtronic PLC, Abbott Laboratories, and Johnson & Johnson.
- Technological improvements and higher neurosurgical volumes are principal trends supporting market expansion.
External Ventricular Drain Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report examines the external ventricular drain market, which rises from $1.50 Billion in 2023 to $2.95 Billion by 2033 at a 6.8% CAGR for 2023 to 2033. Growth is supported by higher incidence of neurological conditions, expanding neurosurgical procedures, and continued device innovation that improves drainage management. Market structure covers product categories such as ventricular drainage systems and accessories, end users like hospitals and ambulatory surgical centers, and applications including neurosurgery and trauma. Regional performance is mapped, noting North America as the largest market. The competitive landscape features established medical-device firms including B. Braun Melsungen AG, Medtronic PLC, Abbott Laboratories, and Johnson & Johnson. Research combines expert interviews, published company materials, and internal validation to highlight trends, unmet needs, and adoption drivers that influence procurement and development priorities across healthcare settings.
Key Growth Drivers
- Rising volume of neurosurgeries increases demand for reliable intracranial pressure management solutions.
- Advances in drainage system design improve safety and usability, encouraging clinical uptake.
- Growing prevalence of neurological disorders and traumatic brain injuries creates sustained procedural need.
- Expansion of healthcare infrastructure in multiple regions supports broader access to specialized care.
- Ongoing product innovation and regulatory approvals enable new solutions from leading medical-device firms.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $2.95 Billion |
| Top Companies | B. Braun Melsungen AG, Medtronic PLC, Abbott Laboratories, Johnson & Johnson |
| Published Date | 11 October 2024 |
| Last Modified Date | 25 May 2026 |
External Ventricular Drain Market Overview
Customize External Ventricular Drain Market Report market research report
- ✔ Get in-depth analysis of External Ventricular Drain market size, growth, and forecasts.
- ✔ Understand External Ventricular Drain's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in External Ventricular Drain
What is the Market Size & CAGR of External Ventricular Drain Market Report market in 2023?
External Ventricular Drain Industry Analysis
External Ventricular Drain Market Segmentation and Scope
Tell us your focus area and get a customized research report.
External Ventricular Drain Market Report Market Analysis Report by Region
Europe External Ventricular Drain Market Report:
Europe grows from $0.39 Billion in 2023 to $0.77 Billion in 2033. 39 Billion in 2023 to $0.77 Billion in 2033, supported by growing neurosurgical activity and regulatory pathways that enable adoption of new devices. Healthcare investments and clinical focus on neurological care underpin regional expansion.Asia Pacific External Ventricular Drain Market Report:
Asia Pacific grows from $0.29 Billion in 2023 to $0.57 Billion in 2033. 29 Billion in 2023 to $0.57 Billion in 2033 as expanding healthcare infrastructure and rising demand for neurological interventions broaden access to external ventricular drains across hospital networks and specialty clinics.North America External Ventricular Drain Market Report:
North America is largest regional market, rising from $0.55 Billion in 2023 to $1.09 Billion in 2033. This growth reflects established clinical infrastructure, high procedural volumes, and active adoption of advanced drainage systems by hospitals and specialty centers.South America External Ventricular Drain Market Report:
Latin America grows from $0.08 Billion in 2023 to $0.15 Billion in 2033. 08 Billion in 2023 to $0.15 Billion in 2033, with gradual improvements in neurosurgical services and increasing availability of specialized devices contributing to market development in the region.Middle East & Africa External Ventricular Drain Market Report:
Middle East and Africa grows from $0.19 Billion in 2023 to $0.37 Billion in 2033. 19 Billion in 2023 to $0.37 Billion in 2033, driven by incremental healthcare capacity building and selective uptake of monitoring and drainage solutions in tertiary care facilities.Tell us your focus area and get a customized research report.
Research Methodology
External Ventricular Drain Market Analysis By Product
The EVD market, by product, is mainly divided into ventricular drainage systems and accessories. Ventricular drainage systems account for approximately 83.57% of the market in 2023, with a size of $1.25 billion anticipated to grow to $2.46 billion by 2033. Accessories make up the remaining segment, indicating their essential role in complete treatment protocols.
External Ventricular Drain Market Analysis By Application
By application, the EVD market includes neurosurgery, trauma, neurological disorders, and others. Neurosurgery is the leading segment, comprising 53.91% share in 2023, expected to grow from $0.81 billion to $1.59 billion by 2033, reflecting the critical demand for these systems in advanced surgical procedures.
External Ventricular Drain Market Analysis By End User
In terms of end-users, hospitals dominate the market with a share of 60.09% in 2023, growing from $0.90 billion to $1.77 billion by 2033 due to their integral role in patient surgeries and intensive care.
External Ventricular Drain Market Analysis By Region
Regional analysis shows strong variances in market growth, with North America leading overall EVD usage, followed closely by Europe. Emerging markets in Asia-Pacific and Latin America are also expected to reflect substantial growth by enhancing healthcare facilities.
External Ventricular Drain Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in External Ventricular Drain Industry
B. Braun Melsungen AG:
A leading global manufacturer of precision medical devices, B. Braun specializes in innovative solutions for managing cranial pressure, thereby enhancing patient safety and treatment outcomes.Medtronic PLC:
Medtronic is recognized for its advanced neurosurgery technologies, including EVD systems that are pivotal in cranial surgery procedures, aiming for technological innovations and superior patient care.Abbott Laboratories:
Abbott develops and delivers innovative healthcare solutions, including devices for effective cerebrospinal fluid management, contributing significantly to the EVD market.Johnson & Johnson:
Known for a wide range of healthcare products, Johnson & Johnson focuses on improving surgical outcomes with its compliant and effective EVD systems.We're grateful to work with incredible clients.
FAQs
What is the market size of the External Ventricular Drain Market Report in 2023?
The market size in 2023 is $1.50 Billion, based on reported figures for the external ventricular drain sector and used as the baseline for the 2023 to 2033 forecast period.
How big will the market be in 2033?
The market is projected to reach $2.95 Billion by 2033, reflecting the reported end-period value for the 2023 to 2033 forecast window without further numerical adjustments.
What is CAGR for the forecast period?
The reported compound annual growth rate for 2023 to 2033 is 6.8%, applied to the market trajectory from $1.50 Billion in 2023 to $2.95 Billion in 2033.
Is there a single fastest Growing region in the External Ventricular Drain Market Report market?
No single fastest-growing region is stated for the External Ventricular Drain Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies lead the external ventricular drain market?
Top companies listed include B. Braun Melsungen AG, Medtronic PLC, Abbott Laboratories, and Johnson & Johnson, reflecting major medical-device participation in this sector.
How do product segments appear in the report?
Product segmentation includes ventricular drainage systems and accessories, with subsegment breakdowns provided to reflect device and support-product categories used in clinical settings.
What end users are covered in the analysis?
End-user categories detailed include hospitals, ambulatory surgical centers, and research institutes, illustrating primary facilities where external ventricular drains are deployed.
Why are technological advances highlighted as trends?
Technological advances are emphasized because improvements in materials and system integration enhance device performance and usability, supporting wider clinical adoption and procedural efficiency.